All Stories

  1. Disparities in the Uptake of COVID‐19 Vaccination Between Māori and Non‐Māori in Aotearoa New Zealand
  2. Cross-Cultural Adaptation and Application of the One-Parameter Item Response Model to the Santa Clara Brief Compassion Scale (SCBCS)
  3. Validating the depression anxiety stress scales (DASS-21) across Germany, Ghana, India, and New Zealand using Rasch methodology
  4. Investigating the contribution of socio-economic position to ethnic inequalities in severe COVID-19 outcomes: population-based mediation analyses of national linked Scottish data
  5. Enhancing the Precision of the Revised Life Orientation Test (LOT-R) across Germany, Ghana, India, and New Zealand Using Rasch Methodology
  6. A cross-country network analysis of disease infodemics: Looking through the lens of the COVID-19 pandemic
  7. Generative AI for Tabular Data Synthesis
  8. Enhancing the Precision of the Self-Compassion Scale Short Form (SCS-SF) with Rasch Methodology
  9. Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study
  10. Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study
  11. Caveats in reporting of national vaccine uptake
  12. Enhancing public research on citizen data: An empirical investigation of data synthesis using Statistics New Zealand’s Integrated Data Infrastructure
  13. Validating a tool for estimating the risk of severe COVID-19 outcomes in Scottish adults
  14. Validation and Cultural Adaptation of the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S) in German
  15. Developing the EAVE III platform for future health crises
  16. Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study
  17. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  18. Understanding and reporting odds ratios as rate-ratio estimates in case-control studies
  19. Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose
  20. Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study
  21. Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland
  22. Herpes zoster vaccine safety in the Aotearoa New Zealand population: a self-controlled case series study
  23. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  24. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
  25. Using Critical Success Index or Gilbert Skill Score as composite measures of positive predictive value and sensitivity in diagnostic accuracy studies: Weather forecasting informing epilepsy research
  26. Implications for COVID-19 vaccine uptake: A systematic review
  27. A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection
  28. Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study
  29. Case-control study developing Scottish Epilepsy Deaths Study Score to predict epilepsy-related death
  30. BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland
  31. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
  32. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  33. Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collect...
  34. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study
  35. A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection
  36. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
  37. Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales
  38. Risk of COVID-19 hospitalizations among school-aged children in Scotland: A national incident cohort study
  39. Characterising adults in Scotland who are not vaccinated against COVID-19
  40. Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
  41. The Scottish Epilepsy Deaths Study Score (SEDS Score): a risk prediction model for epilepsy-related deaths
  42. Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data
  43. Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people
  44. Publisher Correction: Development and validation of a multivariable mortality risk prediction model for COPD in primary care
  45. Development and validation of a multivariable mortality risk prediction model for COPD in primary care
  46. Impact on emergency and elective hospital-based care in Scotland over the first 12 months of the pandemic: interrupted time-series analysis of national lockdowns
  47. Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis
  48. BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era
  49. First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales
  50. Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data
  51. Author Correction: SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
  52. Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data
  53. Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study
  54. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
  55. Cohort Profile: The COVID-19 in Pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy
  56. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
  57. The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination
  58. The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment
  59. Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)
  60. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
  61. External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland
  62. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study
  63. Association between multimorbidity and mortality in a cohort of patients admitted to hospital with COVID-19 in Scotland
  64. COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study
  65. A national study of epilepsy‐related deaths in Scotland: Trends, mechanisms, and avoidable deaths
  66. Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
  67. Ethnic and social inequalities in COVID-19 outcomes in Scotland: protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)
  68. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study
  69. Hormone Replacement Therapy and Risk of Severe Asthma Exacerbation in Perimenopausal and Postmenopausal Women: 17-Year National Cohort Study
  70. Stacking segment-based CNN with SVM for recognition of atrial fibrillation from single-lead ECG recordings
  71. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
  72. Phylodynamics reveals the role of human travel and contact tracing in controlling the first wave of COVID-19 in four island nations
  73. Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database
  74. Hormone replacement therapy and asthma onset in menopausal women: National cohort study
  75. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
  76. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand
  77. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality
  78. Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing
  79. Postlicensure herpes zoster vaccine effectiveness: systematic review protocol
  80. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand
  81. Tutor and international student perspectives on an action research project: use of a business strategy simulation with mixed nationality cohorts
  82. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study
  83. Hormonal contraception and the risk of severe asthma exacerbation: 17-year population-based cohort study
  84. COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data
  85. Validating the accuracy of administrative healthcare data identifying epilepsy in deceased adults: A Scottish data linkage study
  86. Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis
  87. Does use of hormonal contraceptives impact on exacerbations and control in reproductive-age women with asthma? A 17-year population-based cohort study
  88. Hormonal contraceptives and onset of asthma in reproductive-age women: Population-based cohort study
  89. The UK hibernated pandemic influenza research portfolio: triggered for COVID-19
  90. Informing the public health response to COVID-19 (and lessons learnt for future pandemics): a systematic review of risk factors for disease, severity, and mortality.
  91. Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data
  92. The accuracy of using administrative healthcare data to identify epilepsy cases: A systematic review of validation studies
  93. Predicting the onset of type 2 diabetes using wide and deep learning with electronic health records
  94. 11.42 The scottish epilepsy deaths study (SEDS): identifying avoidable epilepsy-related deaths
  95. Seasonal Influenza Vaccine Effectiveness in People With Asthma: A National Test-Negative Design Case-Control Study
  96. Epilepsy-related and other causes of mortality in people with epilepsy: A systematic review of systematic reviews
  97. The UK's pandemic influenza research portfolio: a model for future research on emerging infections
  98. Helping GPs predict asthma attacks using Machine Learning
  99. Inquiry Into Graduate Attributes: Reviewing the Formal and Informal Management Curricula
  100. RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit
  101. Exogenous sex steroid hormones and asthma in females: protocol for a population-based retrospective cohort study using a UK primary care database
  102. Accuracy and utility of using administrative healthcare databases to identify people with epilepsy: a protocol for a systematic review and meta-analysis
  103. Improving predictive asthma algorithms with modelled environment data for Scotland: an observational cohort study protocol
  104. Development of a portable blood salvage and autotransfusion technology to enhance survivability of personnel requiring major medical interventions in austere or military environments
  105. Retrospective cohort study of breast cancer incidence, health service use and outcomes in Europe: a study of feasibility
  106. Effectiveness of Influenza Vaccines in Asthma: A Systematic Review and Meta-Analysis
  107. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease
  108. External validation of a COPD prediction model using population-based primary care data: a nested case-control study
  109. A Process Model of Dynamic Capability Development: Evidence from the Chinese Manufacturing Sector
  110. Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study
  111. P133 Safety and effectiveness of influenza vaccines in people with asthma: a systematic review and meta-analysis
  112. Developing health information by ethnic status in Europe: a pilot data linkage study in Scotland
  113. Seasonal influenza vaccine effectiveness in people with asthma: A systematic review
  114. Projecting the COPD population and costs in England and Scotland: 2011 to 2030
  115. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases
  116. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children
  117. The Practice of Professional Doctorates
  118. Will moving from Read coding system to SNOMED-CT improve coding in primary care?
  119. Building a recruitment database for asthma trials: a conceptual framework for the creation of the UK Database of Asthma Research Volunteers
  120. Cardiovascular and neuropsychiatric risks of varenicline – Authors' reply
  121. Effectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocol
  122. Ethnic variations in asthma hospital admission, readmission and death: a retrospective, national cohort study of 4.62 million people in Scotland
  123. Pilot study linking primary care records to Census, cardiovascular hospitalization and mortality data in Scotland: feasibility, utility and potential
  124. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? – Authors' reply
  125. P218 The epidemiological, healthcare and societal burden and costs of asthma in the UK and member nations: analyses of national databases
  126. Challenges of harmonising data from UK national health surveys: a case study of attempts to estimate the UK prevalence of asthma
  127. Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
  128. Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study
  129. Ethnic variations in morbidity and mortality from lower respiratory tract infections: a retrospective cohort study
  130. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
  131. Language, relationships and skills in mixed-nationality Active Learning classrooms
  132. Risk of respiratory hospitalization and death, readmission and subsequent mortality: scottish health and ethnicity linkage study
  133. Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease
  134. Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009
  135. Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales—a study protocol
  136. Explaining ethnic inequalities in health in Scotland: a pilot study linking primary care to census data to account for ethnic variations in cardiovascular disease
  137. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
  138. Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD
  139. Prevalence of polypharmacy in a Scottish primary care population
  140. Epidemiology of Asthma
  141. Integrating Telehealth Care-Generated Data With the Family Practice Electronic Medical Record: Qualitative Exploration of the Views of Primary Care Staff
  142. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study – exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine
  143. Models for estimating projections for the prevalence and disease burden of chronic obstructive pulmonary disease (COPD): systematic review protocol
  144. Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
  145. Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE) - use of a unique community and laboratory national linked dataset
  146. Association Between Prescribing of Cardiovascular and Psychotropic Medications and Hospital Admission for Falls or Fractures
  147. Practical methodological strategies for individual patient data systematic reviews
  148. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study
  149. Pandemic influenza vaccination for healthcare workers in primary care: good progress, but higher uptake required
  150. Diagnosis and treatment of depression following routine screening in patients with coronary heart disease or diabetes: a database cohort study
  151. Adequate Levels of Adherence with Controller Medication Is Associated with Increased Use of Rescue Medication in Asthmatic Children
  152. Factors associated with duration of new antidepressant treatment: analysis of a large primary care database
  153. A retrospective cohort study assessing patient characteristics and the incidence of cardiovascular disease using linked routine primary and secondary care data
  154. Seasonal Influenza Vaccine Effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set
  155. Risk of prostate cancer associated with benign prostate disease: a primary care case–control study
  156. Five-Year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction
  157. Paracetamol prescribing in primary care: too little and too much?
  158. Learning conversations as reflective practice
  159. P2-284 The impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a six-year population-based repeated cross-sectional study
  160. Impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a 6-year population-based repeated cross-sectional study
  161. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice
  162. Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysis
  163. Incidence, prevalence, and trends of general practitioner–recorded diagnosis of peanut allergy in England, 2001 to 2005
  164. Using Routinely Collected Prescribing Data to Determine Drug Persistence for the Purpose of Pharmacovigilance
  165. Using primary care prescribing databases for pharmacovigilance
  166. Considerable differences exist between prevalent and incident myocardial infarction cohorts derived from the same population
  167. P74 British asthma guideline revision does affect prescribing patterns in children
  168. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting  -agonists and corticosteroids
  169. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients
  170. Vaccine effectiveness in pandemic influenza – primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.
  171. Adrenaline is first line treatment for the emergency treatment of anaphylaxis
  172. Use and safety of long-acting β2-agonists for pediatric asthma
  173. Trends in the epidemiology of asthma in England: a national study of 333,294 patients
  174. Trends in the epidemiology of smoking recorded in UK general practice
  175. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland
  176. Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases
  177. Five year prognosis in patients with angina identified in primary care: incident cohort study
  178. Trends in the epidemiology and prescribing of medication for eczema in England
  179. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People
  180. Incidence and prevalence of multiple allergic disorders recorded in a national primary care database
  181. Introduction of a new incentive and target-based contract for family physicians in the UK: good for older patients with diabetes but less good for women?
  182. The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
  183. Will Snomed-ct Improve Our Understanding Of The Disease Burden Posed By Allergic Disorders?
  184. Adolescent Females and Hormonal Contraception: A Retrospective Study in Primary Care
  185. Evidence for prolonged prescribing of aspirin–clopidogrel combination in Scottish primary care
  186. The Potential for Interaction between Warfarin and Coprescribed Medication
  187. Understanding the reasons for poor asthma outcomes in ethnic minorities: welcome progress, but important questions remain
  188. The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care
  189. Will Systematized Nomenclature of Medicine-Clinical Terms improve our understanding of the disease burden posed by allergic disorders?
  190. The filaggrin gene mutation, atopic dermatitis and asthma
  191. Are different groups of patients with stroke more likely to be excluded from the new UK general medical services contract? A cross-sectional retrospective analysis of a large primary care population
  192. Authors' response: Homeopathy is safe and does not lack positive evidence in clinical trials/Scottish GPs use of Homeopathy
  193. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
  194. Gender-specific presentations for asthma, allergic rhinitis and eczema in primary care
  195. Homoeopathic and herbal prescribing in general practice in Scotland
  196. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study
  197. Effect of the UK Incentive-Based Contract on the Management of Patients With Stroke in Primary Care
  198. Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders
  199. Adolescent use of the combined oral contraceptive pill: a retrospective observational study
  200. Changing incidence of respiratory presentations in primary care fact or artefact?
  201. Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care
  202. Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care
  203. Paediatric homoeopathy in general practice: where, when and why?
  204. Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology
  205. Evidence for inequalities in the management of coronary heart disease in Scotland
  206. National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland
  207. Off-label prescribing to children in primary care: retrospective observational study
  208. Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study
  209. Inadequacies in UK primary care allergy services: national survey of current provisions and perceptions of need
  210. Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care
  211. Burden of corticosteroids in children with asthma in primary care: retrospective observational study
  212. Coincidence of immune-mediated diseases driven by Th1 and Th 2 subsets suggests a common aetiology. A population-based study using computerized General Practice data
  213. Changing asthma prescribing in primary care 1995–1998